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ANALYSIS OF FIXED-RATIO BEHAVIOR MAINTAINED
BY DRUG REINFORCERS
PAUL SKJOLDAGER, GAIL WINGER, AND JAMES H. WOODS
UNIVERSITY OF MICHIGAN
Behavior maintained by intravenously delivered alfentanil, cocaine, or ketamine was assessed using a
fixed-ratio schedule of reinforcement. As the dose of each drug was increased, rate of responding also
increased up to a maximum. Further increases in dose resulted in decreased response rates (inverted
U-shaped curve). An analysis of postreinforcement-pause-time and run-time measures for the ascending
limb of the inverted U-shaped functions revealed that behavior was characterized by systematic
decreases in both pause time and run time as dose and rate increased. An examination of the descending
limb of the dose-response functions revealed that lowered response rates for cocaine and ketamine
were correlated with increases in run time and small and inconsistent effects on postreinforcement
pause time. Behavior maintained by rate-reducing doses of alfentanil was characterized by lengthened
postreinforcement pauses with small increases in run time. These data suggest that at larger doses,
drug reinforcers may have unconditioned or direct effects on the behavior that the drug is maintaining,
and more important, that the nature of these unconditioned effects depends on the drug that is
maintaining behavior.
Key words: fixed-ratio schedule, run time, postreinforcement pause, self-administration, alfentanil,
cocaine, ketamine, lever press, rhesus monkeys
The relationship between reinforcer mag-
nitude and overall rate of operant behavior
maintained under fixed-ratio (FR) schedules
of reinforcement has been described as direct,
inverse, or as an inverted U-shaped function.
The specific shape of the magnitude-rate func-
tion depends on the schedule parameters used
during an experimental session. Some of the
relevant parameters include the range of re-
inforcer magnitudes tested (Downs & Woods,
1974; Kliner, Lemaire, & Meisch, 1988; Le-
maire & Meisch, 1984, 1985), the fixed-ratio
requirement (Kliner et al., 1988; Lemaire &
Meisch, 1984, 1985; Moreton, Meisch, Stark,
& Thompson, 1977; Pickens, Muchow, &
DeNoble, 1981), and the duration of a sched-
uled postreinforcement timeout (Downs &
Woods, 1974; Young & Woods, 1981).
When the FR requirement is held constant
and the effects of a relatively large range of
reinforcer magnitudes are tested, a consistent
finding is that response rates vary inversely
with magnitude of reinforcement. For exam-
ple, response rate was found to vary inversely
with magnitude of reinforcement in rats whose
behavior was maintained by food, cocaine, or
amphetamine under an FR 1 schedule of re-
inforcement (Pickens & Harris, 1968; Pickens
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& Thompson, 1968). In addition, an inverse
relationship between concentration of a milk
reinforcer and response rate was found in rats
maintained under FR 30, fixed-interval (FI
60-s) and tandem FR 1 FI 60-s schedules of
reinforcement (Lowe, Davey, & Harzem,
1974).
When a wide range of reinforcer magni-
tudes is assessed, a consistent finding is that
response rate is an inverted U-shaped function
of reinforcer magnitude. That is, reinforcer
magnitude and response rates are directly re-
lated until a point at which further increases
in magnitude of reinforcement result in pro-
gressive decreases in response rates. An in-
verted U-shaped relationship between re-
sponse rate and magnitude of reinforcement
has been observed under a variety of schedule
conditions and with a variety of reinforcers,
including food (Kliner et al., 1988), drugs (e.g.,
Downs & Woods, 1974; Goldberg & Kelleher,
1976; Lemaire & Meisch, 1984; Moreton et
al., 1977; Pickens et al., 1981; Winger, Palmer,
& Woods, 1989; Woolverton, Goldberg, & Gi-
nos, 1984), and electrical stimulation of the
brain (Reynolds, 1958).
The ascending limb of the inverted U-shaped
function has been attributed to an increase in
reinforcing effect as magnitude of reinforcer
increases (Lemaire & Meisch, 1984), whereas
the descending limb of the inverted U-shaped
function has been attributed to one of two fac-
tors: satiation under food reinforcement con-
331
NUMBER 2 (SEPrEMBER)1991, 56,331-343
PAUL SKJOLDAGER et al.
ditions (Hodos & Kalman, 1963; Kliner et al.,
1988; Sidman & Stebbins, 1954), and direct
or unconditioned effects induced by drugs at
high doses (Downs & Woods, 1974; Pickens
& Thompson, 1968) or high-voltage electrical
stimulation of the brain (Reynolds, 1958).
To examine more closely the effects of re-
inforcer magnitude on operant response rates,
some researchers (e.g., Felton & Lyon, 1966;
Lowe et al., 1974) have performed a molecular
analysis of the behavior whereby overall rate
is broken down into temporal components. For
example, behavior maintained under an FR
schedule of reinforcement has been character-
ized by a pause that precedes a steady rate of
responding until the next reinforcer is ob-
tained. The two temporal components most
often analyzed with respect to FR behavior
are (a) the time to initiate the response se-
quence (postreinforcement pause), and (b) the
time to complete the FR schedule requirement
(run time).
With regard to food-maintained behavior,
the relationship between postreinforcement
pause and reinforcer magnitude has been de-
scribed as direct (Lowe et al., 1974; Staddon,
1970), inverse (Meunier & Starratt, 1979;
Powell, 1969), or U-shaped (Kliner et al.,
1988) depending upon the rate changes pro-
duced by variations in reinforcer magnitude.
However, unlike postreinforcement pause, run
time or running rate has not been found to
vary in any systematic manner with overall
response rate or manipulations of reinforcer
magnitude (Kliner et al., 1988; Lowe et al.,
1974; Meunier & Starratt, 1979; Powell,
1969).
When drugs are used to maintain behavior,
they may have a greater likelihood of dis-
rupting behavior than does food, and the pat-
tern of this disruptive effect may vary among
drugs. An indication that drugs from phar-
macologically different classes may differen-
tially affect pause time or run time comes from
work by Downs and Woods (1974). Cumu-
lative records of codeine- or cocaine-reinforced
responding obtained at doses that lie along the
descending limb of the rate-magnitude func-
tion suggested that increases in unit dose of
codeine resulted in increases in pause time and
irregular response patterns as the FR require-
ment was being completed. An increase in co-
caine dose appeared to produced dose-depen-
dent increases in pause time alone (Downs &
Woods, 1974). Similarly, data obtained by
Pickens and Thompson (1968) suggested that
the descending limb of the inverted U-shaped
function relating rate to unit dose of cocaine
was characterized by systematic changes in
postreinforcement pause time with no effect
on run time or running rate. When unit doses
of cocaine that maintained responding were
delivered noncontingently to rats whose be-
havior was maintained by food, similar dose-
dependent increases in postreinforcement pause
time were observed, suggesting that the direct
or unconditioned effects of cocaine may be
characterized by alterations in postreinforce-
ment pause time (Pickens & Thompson, 1968).
Although these findings suggest that drug-
specific disruptions in FR performance under
high-dose self-administration conditions may
be characterized in terms of their effects on
the temporal elements of FR responding, a
quantitative analysis of these relationships
among several self-administered drugs has not
been performed. Furthermore, a systematic
evaluation of postreinforcement pause and run-
time changes for the ascending limb of the
inverted U-shaped dose-effect function has not
been evaluated under drug reinforcement con-
ditions. To address these issues, we examined
changes in overall response rate, postreinforce-
ment pause times, and run times in monkeys
whose lever-press responding was currently
maintained by alfentanil, cocaine, or ketamine
over a range of doses that produced an inverted
U-shaped function with response rate.
METHOD
Subjects
Ten rhesus monkeys (Macaca mulatta) of
both sexes were used as subjects. Monkeys
weighed between 5.6 and 9.8 kg and lived in
the experimental chambers with unlimited ac-
cess to water and Purina0 Monkey Chow.
Monkeys were surgically implanted with in-
travenous silastic catheters according to the
procedure used by Winger et al. (1989). All
subjects had moderate to extensive self-admin-
istration histories (several months to years) and
were exposed to a variety of pharmacological
agents prior to the start of this experiment.
Apparatus
Monkeys were permanently housed in
stainless steel cages (83.3 cm by 76.2 cm by
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91.4 cm deep). The front, top, and bottom of
the cage were made of barred stainless steel,
and a pan was located below the floor to collect
animal waste. Located on the wall to the left
of the barred front door was a response and
stimulus panel 15.4 cm on a side, approxi-
mately 10 cm from the front and 19 cm from
the bottom of the cage. Near the top of the
stimulus panel were three circular openings
(2.5 cm), separated by 2.5 cm, that were cov-
ered by clear plastic. The center opening could
be illuminated from behind by a 5-W green
Christmas-tree bulb, the right opening by a
red bulb, and the leftmost opening was unlit
at all times. Centered below the right and left
openings were response levers (Model 121-07,
BRS-LVE) capable of being operated by 10
to 15 g (0.10 to 0.15 N) of force. The exper-
imental contingencies were programmed and
data were recorded using IBM PCjr@ com-
puters located in an adjacent room.
Each monkey wore a stainless steel harness
to which a jointed hollow restraining arm was
attached. The catheter passed from the monkey
through the restraining arm to the outside of
the cage, where it attached to a roller infusion
pump (Watson and Marlow Co., Model
MHRK 55) and necessary filters, valves, and
bags of sterile vehicle and drug solutions. The
pumps were calibrated to deliver 0.2 mL/s.
The restraining- and catheter-protection arm
and stainless steel harness have been described
in detail elsewhere (see Deneau, Yanagita, &
Seevers, 1969; Winger et al., 1989).
Procedure
Monkeys were trained under the experi-
mental contingencies with a method described
in detail by Winger et al. (1989). All subjects
received two experimental sessions daily, with
sessions starting at approximately 10:00 a.m.
and 4:00 p.m. Each session was composed of
four response periods, during each of which
one of four doses of drug was delivered con-
tingent on appropriate responses. Response
periods within each session were separated by
a 10-min timeout period, and each response
period lasted until 25 min elapsed or the sub-
ject received 20 injections.
A response period was signaled by illumi-
nation of a red light located above the operative
(right) response lever; completion of 30 lever-
press responses (FR 30) on that lever in the
presence of the red light resulted in activation
of an infusion pump (signaled by a green light)
and was followed immediately by a 45-s time-
out, during which both lights were unlit and
lever-press responses had no programmed con-
sequence. The doses of drug differed by 0.5
log (base 10) steps and were controlled by
varying the duration of pump action from 0.5
to 16.7 s. For example, a 0.01 mg/kg/mL
stock solution of cocaine infused with pump
durations of 0.5, 1.78, 5.0, or 16.7 s corre-
sponded to cocaine doses of 0.001, 0.003, 0.01,
and 0.03 mg/kg/inj, respectively. When re-
sponse rates were a direct (not inverted
U-shaped) function over the baseline dose
range, it was necessary to increase the dose
range by an increment of 0.5 log (base 10)
unit. This was accomplished by increasing the
concentration of drug in the stock solution and
using identical infusion durations. For ex-
ample, a 0.03 mg/kg/mL stock solution of
cocaine, infused with the same pump durations
described above, corresponded to cocaine doses
of 0.003, 0.01, 0.03, and 0.1 mg/kg/inj. The
drug doses were available in one of four orders
(counterbalanced using a Latin square) that
were randomly selected across sessions.
Stable FR baseline behavior was main-
tained for 3 subjects with alfentanil, 5 subjects
with cocaine, and 2 subjects with ketamine.
After all subjects were exposed to a dose range
of the baseline drug that produced an inverted
U-shaped function for overall rate (i.e., alfen-
tanil [Janssen Pharmaceuticals], 0.03 to 3.0
,ug/kg/inj; cocaine [Mallinckrodt], 0.001 to 0.1
mg/kg/inj; and ketamine [Vetalar, Fort Dodge
Laboratories], 0.01 to 1.0 mg/kg/inj), subjects
were given the opportunity to self-administer
one and then the other of the two remaining
compounds on several (no more than 25) con-
secutive sessions. The same dose ranges as had
been used for the previous monkeys were used
during crossover substitution sessions. Saline
substitutions were also performed during base-
line conditions in all subjects to determine
whether lever pressing was being maintained
by stimuli associated with drug infusions (e.g.,
the sound of the infusion pump, the stimulus
signaling the infusion, subdermal temperature
changes, pump vibration, etc.) or the drug
stimulus itself. Whereas response rates were
generally low during saline conditions, an oc-
casional subject would require two to three
consecutive saline sessions before response rates
averaged less than 0.5 response per second.
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Overall rate, postreinforcement pause time, and
run-time data obtained during several saline
sessions were averaged over the four response
periods to obtain a single saline value for each
dependent variable.
During drug baseline and substitution con-
ditions, criterion self-administration perfor-
mance required overall response rates to be at
least one response per second at at least one
dose, and, either a direct, inverse, or inverted
U-shaped function of overall rate with dose.
During substitution conditions, subjects that
did not maintain criterion performance for at
least two consecutive sessions over a total of
25 sessions were returned to baseline condi-
tions. If response rates were a direct function
of unit dose, subjects that met criterion for two
consecutive sessions were provided the oppor-
tunity to self-administer a 0.5 log unit higher
dose range of the substituted drug over sub-
sequent sessions until a dose was reached that
produced a decrease in overall rate of response.
Subjects were returned to baseline drug con-
ditions and saline control trials between
substitution tests. All 10 subjects met the self-
administration criteria on at least two occa-
sions for cocaine and alfentanil, whereas 3
subjects (2 cocaine-baseline and 1 alfentanil-
baseline subject) failed to meet criterion self-
administration performance under ketamine
self-administration conditions.
Three dependent measures were used to de-
scribe self-administration behavior for all drugs
at each dose: (a) overall rate was the total
number of responses divided by the total
amount of time available to respond per 25-
min response period (i.e., excluding timeout
and infusion time), (b) pause time was the
amount of time from the onset of a signaled-
response period to the first response (postre-
inforcement pause), and (c) run time was the
amount of time from the first response to the
completion of 30 responses. Run-time mea-
sures were discarded when fewer than 30 re-
sponses were emitted. Because the first pause
of a response period (the time from the start
of the response period to the first response)
and the first 30 responses were not preceded
by drug injections, these initial data were omit-
ted from the following analyses. The number
of observations at each dose for each subject
under the various drug and saline substitution
conditions that were used to compute average
overall rate, pause time, and run time mea-
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Table 2
Overall rate, postreinforcement pause, and run-time data for monkeys self-administering al-
fentanil. Saline data are shown only for alfentanil baseline subjects. The values are means
(SEM) based on the number of response periods shown in Table 1.
Alfentanil (,ug/kg/inj)
Monkey Saline 0.03 0.1 0.3 1.0 3.0
Overall rate (r/s)
R639 0.75 (0.02) 0.79 (0.02) 0.42 (0.09) 0.80a (0.28) 0.10 (0.03)
80N106 0.27 (0.10) 0.49 (0.15) 1.53a (0.20) 1.12 (0.11) 0.33
P671 0.04 (0.02) 0.17 (0.04) 0.88a (0.18) 0.85 (0.17) 0.31 (0.04)
M123 0.07 (0.04) 0.11 (0.06) 0.42 (0.08) 0.86a (0.13) 0.41 (0.00)
C489 0.03 (0.01) 0.08 (0.02) 0.87 (0.26) 2.26a (0.12) 1.59
C478 0.24 (0.02) 0.27 (0.05) 0.71 (0.20) 1.75 (0.22) 2.12a (0.20) 0.36 (0.02)
Cl 0.20 (0.02) 0.36 (0.13) 0.66 (0.20) 1.58 (0.26) 2.22a (0.43) 0.56 (0.10)
82-217 0.13 (0.02) 0.15 (0.03) 0.35 (0.13) 1.18 (0.21) 1.43a (0.16) 0.40 (0.20)
ill 0.08 (0.03) 0.24 (0.06) 0.31 (0.06) 1.23a (0.34) 0.49 (0.09)
288 0.10 (0.01) 0.26 (0.11) 0.45 (0.24) 2.29a (0.69) 0.43 (0.03)
Postreinforcement pause (s)
R639 439.67 (129.62) 385.62 (88.44) 62.45 (35.44) 56.19a (21.25) 225.99 (49.41)
80N106 119.73 (53.64) 62.36 (13.04) 8.30- (1.84) 8.94 (0.65) 46.31
P671 413.22 _b 84.85 (32.29) 16.02a (4.89) 13.15 (4.84) 36.48 (4.49)
M123 12.85 (6.75) 42.45 (14.27) 17.13 (6.87) 2.90a (0.82) 13.35 (5.05)
C489 246.75 (224.85) 444.80 (144.05) 44.60 (31.07) 7.15a (0.94) 13.20
C478 128.30 (20.87) 136.16 (22.74) 69.76 (18.87) 13.04 (4.37) 8.28a (2.15) 76.86 (0.62)
Cl 149.45 (20.82) 107.48 (25.90) 91.45 (30.39) 17.17 (7.43) 9.89a (3.87) 33.36 (11.83)
82-217 150.87 (28.15) 143.93 (30.96) 182.80 (70.91) 24.38 (9.53) 9.65a (1.53) 25.23 (10.96)
ill 90.65 (37.88) 45.31 (18.57) 59.49 (28.34) 20.71a (5.38) 47.53 (9.99)
288 83.22 (36.75) 76.66 (29.02) 35.17 (16.04) 7.35a (5.47) 49.30 (2.52)
Run time (s)
R639 71.68 (41.72) 212.85 (144.68) 43.38 (10.91) 34.26a (11.78) 163.19 (38.85)
80N106 40.66 (24.80) 15.86 (3.80) 13.13a (2.12) 19.39 (2.25) 51.51
P671 14.46 _b 71.78 (20.75) 31.82a (8.11) 30.58 (7.66) 60.70 (10.35)
M123 320.30 _b 452.60 (154.70) 225.10 (45.75) 134.60a (14.96) 122.00 (24.70)
0489 459.50 _b 154.30 (18.95) 90.90 (8.57) 26.30' (1.19) 12.61
0478 25.19 (4.33) 16.81 (2.88) 33.79 (13.17) 9.91 (1.01) 8.26a (0.80) 7.99 (1.23)
Cl 32.85 (12.61) 37.97 (20.76) 20.04 (7.64) 15.92 (4.33) 14.55a (4.55) 25.67 (5.11)
82-217 85.83 (39.68) 56.19 (22.38) 20.33 (6.87) 24.19 (7.24) 16.21' (3.95) 27.46 (5.11)
ill 143.57 (135.33) 137.29 (71.07) 51.85 (13.51) 13.47a (3.57) 24.52 (8.41)
288 265.78 (10.33) 205.40 (100.91) 93.23 (80.40) 10.56' (2.02) 21.25 (2.81)
aPeak dose.
bSEM not available because only one observation was obtained at this dose.
RESULTS
Averaged overall rate, pause-time, and run-
time measures for each subject at each dose of
alfentanil, cocaine, or ketamine are presented
in Tables 2, 3, and 4 for each drug, respec-
tively. Striking individual differences emerged
among subjects in terms of (a) the drug that
maintained the highest rate of responding and
(b) the response rates maintained at each dose.
For example, a cocaine-baseline monkey
(80N 106) showed an average response rate of
1.12 responses per second when 0.03 mg/kg!
inj cocaine was response contingent (the high-
est rate for this subject) and emitted maximum
response rates of 1.53 responses per second and
1.67 responses per second with 0.3 A.g/kg/inj
alfentanil and 0.03 mg/kg/inj ketamine, re-
spectively. In comparison, an alfentanil-base-
line monkey (82-2 17) maintained maximum
average rates of 1.43 and 3.92 responses per
second with 1.0 jsg/kg/inj alfentanil and 0.03
mg/kg/inj cocaine, respectively, but did not
maintain response rates consistently over 1.00
response per second during the ketamine-sub-
stitution condition. Furthermore, whereas one
dose usually maintained the highest rate of
responding for most subjects, at least 2 subjects
under each drug condition showed depressed
rates at doses that maintained maximal rates
in the other monkeys. For example, Subjects
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Table 3
Overall rate, postreinforcement pause, and run-time data for monkeys self-administering co-
caine. Saline data are shown only for cocaine baseline subjects. The values are means (SEM)
based on the number of response periods shown in Table 1.
Cocaine (mg/kg/inj)
Monkey Saline 0.001 0.003 0.01 0.03 0.1
Overall rate (r/s)
R639 0.25 (0.10) 0.35 (0.11) 0.75 (0.17) 1.54 (0.25) 2.12a (0.30) 0.82 (0.13)
80N106 0.15 (0.02) 0.30 (0.26) 0.63 (0.36) 0.73 (0.47) 1.12a (0.15) 0.73 b
P671 0.17 (0.03) 0.13 (0.02) 0.28 (0.05) 1.03 (0.11) 1.36a (0.11) 0.71 (0.07)
M123 0.31 (0.04) 0.20 (0.04) 0.67 (0.14) 1.20a (0.14) 1.08 (0.13) 0.19 b
C489 0.11 (0.03) 0.17 (0.08) 0.74 (0.15) 2.23 (0.23) 2.83a (0.43) 1.05 (0.51)
C478 0.70 (0.26) 0.51 (0.19) 0.80 (0.30) 2.15a (0.40) 0.38 (0.09)
C1 1.16 (0.45) 1.95 (0.71) 2.48a (0.60) 2.12 (0.49) 0.97 (0.11)
82-217 2.23 (0.29) 2.46 (0.41) 3.81 (0.41) 3.92a (0.54) 2.13 (1.04)
Ill 0.25 (0.00) 0.62 (0.38) 0.51 (0.35) 1.57a (0.42) 0.82 (0.33)
288 0.36 (0.03) 1.00 (0.44) 1.63 (0.37) 1.68a (0.81) 0.54 (0.14)
Postreinforcement pause (s)
R639 217.14 (36.88) 167.13 (92.90) 68.84 (46.73) 8.26 (2.57) 3.76a (1.57) 8.93 (1.69)
80N106 255.20 (18.20) 363.46 (318.80) 121.61 (93.35) 8.89 (0.60) 12.57a (2.90) 26.06 b
P671 89.45 (24.01) 106.88 (28.50) 75.78 (17.51) 21.58 (11.71) 1.93a (0.19) 1.90 (0.38)
M123 73.79 (20.27) 125.40 (26.85) 46.04 (33.80) 3.19a (1.44) 2.15 (0.46) 15.71 b
C489 246.26 (49.43) 223.02 (59.80) 40.81 (7.54) 5.29 (1.28) 4.11a (1.23) 3.26 (0.60)
C478 104.15 (68.25) 49.43 (15.68) 129.72 (92.90) 3.97a (0.67) 55.67 (42.63)
C1 21.69 (12.41) 11.05 (5.74) 3.75a (1.20) 4.44 (1.57) 11.38 (2.79)
82-217 7.85 (3.24) 3.14 (0.63) 1.73 (0.47) 1.42a (0.12) 1.39 (0.32)
Ill 65.43 (26.68) 88.51 (44.36) 51.78 (16.12) 73.66a (61.28) 17.26 (6.13)
288 43.50 (25.36) 55.66 (37.41) 10.49 (4.04) 9.14a (5.72) 39.02 (6.97)
Run time (s)
R639 38.94 (23.62) 54.73 (18.66) 67.41 (29.69) 20.81 (4.37) 18.51a (4.06) 32.75 (5.32)
80N106 166.16 (154.08) 17.91 (9.00) 16.31 (3.53) 13.73 (4.60) 15.30a (4.11) 16.52 b
P671 32.37 (6.11) 93.67 (33.29) 101.20 (24.72) 29.86 (4.28) 25.60a (3.76) 43.69 (3.53)
M123 34.86 (5.87) 72.63 (16.51) 32.23 (2.86) 23.75a (2.64) 29.28 (5.24) 164.48 _b
C489 139.08 (47.09) 103.97 (49.93) 23.71 (9.76) 11.68 (2.22) 8.61a (1.55) 47.21 (9.37)
C478 33.87 (18.50) 32.02 (11.86) 19.63 (3.75) 7.75a (0.57) 28.75 (23.66)
C1 8.82 (0.59) 15.51 (4.55) 12.69a (3.58) 17.15 (7.10) 21.55 (4.78)
82-217 6.94 (1.31) 12.09 (2.64) 6.99 (1.10) 8.45a (2.61) 24.14 (8.51)
Ill 39.03 (21.31) 23.85 (7.30) 26.86 (10.05) 13.38a (5.39) 15.41 (6.37)
288 16.87 (5.91) 19.01 (8.29) 11.68 (3.52) 12.16a (5.26) 22.69 (12.11)
a Peak dose.
bSEM not available because only one observation was obtained at this dose.
80N106 and P671 maintained maximal rates
at 0.3 ,g/kg/inj alfentanil, whereas all other
monkeys showed maximal rates at 1.0 ,g/kg/
inj alfentanil (see Table 2). Monkeys that
emitted highest rates at a dose 0.5 log unit
lower than the dose that maintained maximal
response rates in the other monkeys were not
the same across the drug substitution condi-
tions (e.g., highest response rates at 0.5 log
unit lower doses than the other monkeys were
80N106 and P671 for alfentanil, C1 and M123
for cocaine, and C1 and 80N106 for ketamine).
Although the dose-rate functions for indi-
vidual monkeys were appreciably different, the
total amount of self-infused drug under each
dose condition was not. All subjects were nearly
identical when total drug intake was plotted
as a function of dose (data not shown).
To remove the effects of an individual sub-
ject's sensitivity to a self-administered drug
dose and allow qualitative comparisons to be
made among subjects and across drugs, data
were "peak aligned" based on the dose that
maintained the highest overall response rate.
Thus, the peak alignment method involved
identifying the dose that produced the highest
overall rate of response (peak dose), and ob-
taining pause-time, run-time, and overall rate
values at tested doses in 0.5 log steps above
and below the peak dose. Overall rate, pause-
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Table 4
Overall rate, postreinforcement pause, and run-time data for monkeys self-administering ke-
tamine. Saline data are shown only for ketamine baseline subjects. The values are means (SEM)
based on the number of response periods shown in Table 1.
Ketamine (mg/kg/inj)
Monkey Saline 0.01 0.03 0.1 0.3 1.0
Overall rate (r/s)
R639 0.11 (0.03) 0.38 (0.31) 0.80a (0.27) 0.28 (0.03)
80N106 0.26 (0.23) 1.67a (0.34) 0.57 (0.15) 0.17 (0.01)
P671 0.06 (0.03) 0.05 (0.05) 1.48a (0.26) 0.44 (0.02)
M123b
C489b
C478 0.25 (0.07) 0.80 (0.21) 0.89a (0.17) 0.23 (0.01) 0.11 (0.01)
C1 1.43 (0.86) 2.24a (0.70) 0.46 (0.10) 0.15 (0.02) 0.06 (0.00)
82-217b
Ill 0.12 (0.03) 0.14 (0.04) 0.47 (0.21) 1.52a (0.22) 0.63 (0.04) 0.17 (0.01)
288 0.32 (0.16) 0.31 (0.08) 1.05 (0.21) 1.59a (0.16) 0.51 (0.04) 0.10 (0.00)
Postreinforcement pause (s)
R639 195.16 (48.78) 287.11 (154.15) 27.09a (15.24) 20.41 (9.49)
80N106 227.68 (194.35) 7.65a (2.10) 24.69 (12.44) 119.92 (7.58)
P671 273.06 -c 166.01 -c 2.53a (1.40) 4.33 (0.50)
M123b
C489b
C478 83.87 (5.16) 27.25 (12.48) 14.10a (3.99) 45.38 (10.03) 192.89 (45.87)
C1 53.04 (30.16) 23.23a (13.36) 22.45 (5.54) 60.95 (18.17) 477.58 (34.33)
82-217b
Ill 127.84 (36.89) 138.18 (44.15) 60.23 (31.69) 7.88a (2.37) 6.94 (0.84) 24.84 (7.03)
288 99.69 (19.92) 89.10 (27.21) 78.20 (60.76) 7.53a (1.33) 14.61 (5.89) 181.71 (2.91)
Run time (s)
R639 122.76 (64.79) 16.56 (3.34) 33.22a (16.57) 91.95 (17.33)
80N106 13.33 (5.13) 12.09a (2.07) 25.68 (3.84) 69.60 (2.80)
P671 69.55 -c 25.25 -c 18.49a (2.10) 66.68 (2.84)
M123b
C489b
C478 55.62 (32.98) 19.88 (3.87) 26.69a (7.11) 86.28 (8.41) 99.36 (4.81)
C1 6.82 (2.10) 11.24a (3.35) 73.22 (30.31) 204.76 (66.47) 148.41 (50.81)
82-217b
Ill 241.34 (85.59) 187.35 (68.44) 144.02 (103.68) 18.45a (3.27) 44.92 (4.05) 162.45 (40.59)
288 53.45 (13.69) 71.52 (19.27) 21.07 (8.09) 15.97a (3.04) 52.93 (3.57) 197.93 (41.41)
a Peak dose.
b Data not available because monkey did not meet substitution criteria (see text).
C SEM not available because only one observation was obtained at this dose.
time, and run-time values for each subject at
relative log doses are presented in Figures 1,
2, and 3, for alfentanil, cocaine, and ketamine
self-administration conditions, respectively.
Overall response rate was an inverted
U-shaped function of dose for all drugs (Fig-
ures 1 through 3, top frames). Response rates
under saline conditions were low for all sub-
jects under each drug self-administration con-
dition and were characterized by elevated pause
and run times when compared to the dose
maintaining the highest response rate.
Pause-time data at relative log doses of al-
fentanil, cocaine, and ketamine are shown in
the middle frames of Figures 1, 2, and 3, re-
spectively. An orderly decrease in pause times
as rates increased from the lowest tested dose
to peak dose occurred 25 of 28 times for al-
fentanil, 24 of 28 times for cocaine, and 11 of
12 times for ketamine. Repeated measures
analysis of variance (ANOVA) confirmed the
dose-dependent decrease in pause time from
the peak - 1.5 to peak dose for alfentanil, F(3,
21) = 7.51, p < .01, and cocaine F(3, 21) =
5.921, p < 0.5, and from the peak - 1.0 to
peak dose for ketamine, F(2, 8) = 7.63, p <
.05. Run-time data for each subject at rela-
tive log doses of alfentanil, cocaine, and ket-
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SAL P-1.5 P-1.0 P-0.5 PEAK P+0.5 P+1.0
RELATIVE LOG DOSE
Fig. 1. Peak-aligned overall rate (top panel), pause
time (middle panel), and run time (lower panel) plotted
as a function of relative log dose for each subject under
alfentanil self-administration conditions. Data obtained
under saline substitution conditions during baseline re-
sponse periods are indicated by SAL. Peak dose refers to
the dose of drug that maintained the highest rate of re-
sponding, whereas peak - 1.5, peak - 1.0, and peak -
0.5 refer to doses 1.5, 1, and 0.5 log units lower than peak,
respectively. Peak + 0.5 refers to the relative log dose 0.5
log unit higher than peak dose.
amine are shown in the lower frames of Fig-
ures 1, 2, and 3, respectively. Similar to pause
times, run times decreased in an orderly man-
ner 24 of 28 times for alfentanil, 19 of 28 times
COCAINE







SAL P-1.5 P-1.0 P-0.5 PEAK P+0.5 P+1.0
RELATIVE LOG DOSE
Fig. 2. Peak-aligned overall rate (top panel), pause
time (middle panel), and run time (lower panel) plotted
as a function of relative log dose for each subject under
cocaine self-administration conditions. See Figure 1 for
details.
for cocaine, and 9 of 12 times for ketamine.
Statistical analyses confirmed that run times
were significantly decreased in a dose-related
manner from the peak - 1.5 to peak dose for
alfentanil, F(3, 21) = 5.68, p < .05, and co-
caine, F(3, 21) = 4.98, p < .01, and from the
peak - 1.0 to peak dose for ketamine, F(2, 8)
6.84, p < .05.
When response rates were inversely related
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to drug dose (the descending limb of the in-
verted U-shaped function), differences emerged
between drugs with regard to their effects on
pause time and run time. Under alfentanil self-
administration conditions, pause times in-
creased in an orderly manner from the peak
to the peak + 1.0 dose 1 1 of 12 times, whereas
run times increased in an orderly manner 9 of
12 times (see Table 2 and Figure 1). Because
only 2 subjects had valid data at the peak +
1.0 dose, the statistical analyses were per-
formed over the peak and peak + 0.5 dose
range. ANOVAs revealed that the increase in
run time from peak to the peak + 0. dose
was not statistically reliable, whereas the in-
crease in pause time over this dose range ap-
proached, but did not attain, statistical signif-
icance, F(1, 9) = 4.62, p = .06.
When response rates decreased from peak
to the peak + 1.0 dose for monkeys self-ad-
ministering cocaine, pause time showed an or-
derly increase 8 of 12 times, whereas run time
increased 12 of 12 times (see Table 3 and
Figure 2). As with alfentanil, only 2 subjects
had valid data at the peak + 1.0 dose. There-
fore, these data were analyzed over the peak
to peak + 0.5 dose range. Statistical analyses
confirmed the fact that an increase in run time
occurred from the peak to the peak + 0.5
cocainedose,F(1,9) = 13.54,p < .01,whereas
pause-time increases were not statistically sig-
nificant over this dose range.
Under the ketamine self-administration
condition, an orderly increase in pause time
occurred 12 of 15 times, whereas run-time in-
creases were orderly 14 of 15 times over the
peak to peak + 1.5 dose range (although only
1 subject was tested at the peak + 1.5 dose).
Because 5 of 7 subjects were tested over the
peak to peak + 1.0 dose range, data were
analyzed first over the peak to peak + 0.5 dose
range, and then over the peak to peak + 1.0
dose range. Statistically significant increases
in run time, F(1, 6) = 38.43, p < .01, were
found over the peak to peak + 0.5 dose range,
whereas pause times were not increased sig-
nificantly. However, as ketamine dose increased
from peak to the peak + 1.0 dose, decreases in
response rate were accompanied by increases
in both pause time, F(2, 8) = 9.72, p < .01,
and run time, F(2, 8) = 17.29, p < .01.
To explore more fully the changes in be-
havior occurring when doses were increased




































P-1.0 P-0.5 PEAK P+0.5 P+ 1.0 P+ 1.5
SAL P-1.0 P-0.5 PEAK P+0.5 P+1.0 P+1.5
RELATIVE LOG DOSE
Fig. 3. Peak-aligned overall rate (top panel), pause
time (middle panel), and run time (lower panel) plotted
as a function of relative log dose for each subject under
ketamine self-administration conditions. For details, refer
to Figure 1.
examined the relationship between changes in
rate, expressed as functions of changes in both
run time and pause time. For example, if rate
decreases occurring when dose increased from
the peak to peak + 0.5 dose were reliably
associated with increases in run time for all
subjects self-administering cocaine, then one
would expect a strong inverse relationship to
exist between rate and run time for all subjects.
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Fig. 4. Percentage decrease in rate from peak to peak + 0.5 dose conditions (y axis) plotted as a function of
percentage change in run time (top row) and pause time (bottom row) for each drug. Note that log scales are used for
all axes. Symbols represent the data obtained from a single subject and denote the drug used to maintain baseline self-
administration behavior. Pearson correlation coefficients are presented in the upper right corners, and asterisks reflect
p values: *p < .05, **p < .01. See text for details.
To investigate these relationships, proportion-
change values were computed by dividing rate
of responding obtained at the peak + 0.5 dose
with rate obtained at the peak dose. Propor-
tion-change values for pause time and run time
were similarly computed by dividing values at
peak + 0.5 dose with peak dose values. Be-
cause visual analysis of the frequency distri-
butions for most variables were positively
skewed (data not shown), all values were log
(base 10) transformed prior to the computation
of Pearson correlations. For purposes of dis-
playing the relationships graphically, data were
transformed to percentages by multiplying by
100 and plotted on log-log coordinates.
The relationships between percentage
change in rate expressed as a function of per-
centage change in run time and pause time for
alfentanil, cocaine, and ketamine self-admin-
istering subjects are shown in Figure 4. The
y axis in each frame reflects the percentage of
peak rate when dose increased from peak to
peak + 0.5 dose. Values near the 100% tick
mark on the y axis indicate relatively little
change in rate as dose increased from peak to
peak + 0.5 dose, whereas more substantial
changes (decreases) in rate fall correspond-
ingly lower along the y axis. In a similar man-
ner, run times at the peak + 0.5 dose that did
not differ from peak dose run times fall near
the 100% value in the x axis, whereas relatively
large increases in run time relative to peak
dose run times are reflected in data points lying
to the right along the x axis in the top row of
Figure 4. Regression lines were fit to the data
in each frame using the method of least squares,
and correlation coefficients (shown in the up-
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describe the degree to which data points cluster
along the lines of best fit. In addition, the de-
gree to which rate decreases are associated with
increases in pause time and/or run time are
further described in terms of the slope of the
lines of best fit. Thus, differences in slopes
reflect the fact that either pause time or run
time were more strongly related to decreases
in overall rate.
Changes in rate from peak to peak + 0.5
dose were more consistently reflected in changes
in pause time than run time for subjects self-
administering alfentanil (Figure 4) as evi-
denced by a larger correlation coefficient for
the pause time by rate relationship. Although
a tighter relationship emerged between change
in rate expressed as a change in pause time,
the slopes of the lines of best fit were nearly
identical for the run-time (- 0.74) and pause-
time (- 0.75) measures.
The degree to which changes in rate were
accompanied by changes in run time and pause
time for cocaine-maintained subjects is shown
in the middle frames of Figure 4. Although
the correlation coefficient for pause-time
changes was of greater magnitude than for
run-time changes, half of the subjects that
showed decreases in rates evidenced either no
change or a decrease in pause time. In fact,
Subject Ill showed a decrease in pause time
to 23% of peak accompanied by a decrease in
rate to 56% of peak (Figure 4). These data,
and the fact that the slopes of the lines of best
fit differ markedly among the two measures
(rate by run time -0.59, rate by pause time
-0.30), suggest that decreases in rate from the
peak to peak + 0.5 dose are largely due to
increases in run time.
Performance of ketamine-maintained sub-
jects at rate-decreasing doses was clearly as-
sociated with consistent increases in run time
(slope = -0.55), whereas no relationship
emerged between pause time and rate changes
(slope = -0.05) for these subjects (Figure 4).
These data show that as ketamine dose in-
creased from the peak to peak + 0.5 dose,
subjects that showed greater rate reductions
were more likely to have lengthened run times.
In addition to assessing the degree to which
drugs systematically affect changes in rate as
a function of changes in pause and run time,
data presented in this form permit compari-
sons to be made with regard to the drug main-
taining baseline self-administration behavior.
If, for example, subjects maintained by alfen-
tanil during baseline were more likely to ex-
hibit changes in pause time under cocaine and
ketamine substitution conditions, these effects
may be found by examining Figure 4. Alfen-
tanil-baseline subjects that showed increases
in pause time as rates decreased were no more
likely to exhibit reliable increases in pause
time as rates decreased under high-dose co-
caine and ketamine self-administration con-
ditions (Figure 4). These data, and similar
comparisons made for subjects maintained on
cocaine and ketamine baselines, indicate that
moderate to extensive drug experience under
baseline conditions does not predispose sub-
jects to respond in a particular mode when
other drug reinforcers are available.
DISCUSSION
Contingent delivery of alfentanil, cocaine,
or ketamine following completion of an FR 30
schedule of reinforcement resulted in inverted
U-shaped functions of rate as dose (reinforcer
magnitude) increased. These findings are sim-
ilar to those obtained in other self-administra-
tion experiments (Carroll & Stotz, 1983;
Downs & Woods, 1974; Goldberg & Kelleher,
1976; Moreton et al., 1977; Winger et al.,
1989; Woolverton et al., 1984). Moreover, the
dose that maintained the highest overall rate
of responding differed among the subjects
tested, suggesting that some subjects were more
sensitive than others to either or both the re-
inforcing and unconditioned (rate-decreasing)
effects of these compounds. When the vari-
ability of individual subjects' sensitivity to drug
dose was removed by the peak alignment
method, overall response rates were qualita-
tively similar among the drug reinforcers tested.
The analysis of pause-time and run-time
measures when rates were a direct function of
unit dose indicates that increases in response
rates under alfentanil, cocaine, and ketamine
reinforcement conditions were accompanied by
shortened postreinforcement pauses and run
times. In addition, response rates under ex-
tinction (i.e., saline substitution) conditions
were similar to those obtained under low-dose
drug reinforcement conditions in that overall
rates were low and pause-time and run-time
measures were elevated when compared to be-
havior maintained by the peak dose. That self-
administration behavior maintained by drug
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reinforcers from pharmacologically different
classes revealed similar patterns with regard
to consistent and regular changes in pause-
time and run-time measures on the ascending
limb of the inverted U-shaped function sug-
gests that a single behavioral process may ac-
count for the similarity among drugs observed
here. That is, the increase in rate of respond-
ing, with concomitant decreases in run and
pause times, as doses (reinforcer magnitudes)
increased to the peak dose may be attributed
to an increase in the reinforcing effect of the
self-administered drugs tested here.
With regard to the descending limb of the
magnitude-rate functions, the analysis of
pause-time and run-time measures revealed
differences among the self-administered drugs.
Overall, these data suggest that a self-admin-
istered compound may affect specific measures
of drug-taking behavior and, further, that the
effects may be specific to the drug that is self-
administered. Delayed initiation of an FR
response sequence (i.e., increase in postrein-
forcement pause) characterized the direct ef-
fects of alfentanil, whereas a slowing of
responding during completion of the FR re-
quirement (i.e., increase in run time) char-
acterized the direct effects of cocaine and ket-
amine on self-administration behavior.
Because the drugs differentially affected mo-
lecular aspects of self-administration behavior,
a single behavioral process (self-titration, sa-
tiation) does not account completely for rate
declines at relatively large self-administered
doses.
With regard to cocaine-maintained behavior
in rats (Pickens & Thompson, 1968) and mon-
keys (Downs & Woods, 1974), postreinforce-
ment-pause time increased directly as a func-
tion of cocaine dose for the descending limb of
the magnitude-rate function. Our results
showing that run times reliably increased as
dose of cocaine increased beyond peak dose
levels, and, further, that 5 of the 10 subjects
had shorter postreinforcement pauses at a rate-
decreasing dose than at a peak-cocaine dose
(see Table 3), suggest that a direct relationship
between dose and pause time may not always
develop, despite the findings of such a rela-
tionship by Downs and Woods (1974) and
Pickens and Thompson (1968). It seems likely,
at least for half of the subjects, that the rate-
dependency hypothesis may account for the
direct or unconditioned effects of relatively large
cocaine doses on cocaine self-administration
behavior (Dews, 1958). That is, the pause-
and-run pattern characteristic of FR respond-
ing may have been affected by cocaine such
that under conditions in which response rates
are low (as during the postreinforcement
pause), cocaine served to increase the proba-
bility of responding, whereas under conditions,
that typically engender high response rates (as
when the FR requirement is being completed),
cocaine reduces responding. This interpreta-
tion is consistent with the findings reported by
McAuley and Leslie (1986) on the effects of
amphetamine in rats responding under Fl
schedules of food reinforcement.
Self-administered drugs have dual effects in
the sense that they serve as reinforcers at the
same time and at the same doses that they act
as unconditioned stimuli that disrupt ongoing
response patterns. On the ascending limb of
the unit-dose-response-rate function, there is
a direct relation between dose and the rein-
forcing effect of the drug, although this limb
of the curve is almost certainly modified by the
direct effects of the drug on rates of responding.
As unit dose increases further and rates of
responding decrease (descending limb of the
function), the reinforcing effects of the drug
probably continue to increase but are masked
by the rate-reducing effect of the drug. Ini-
tially, the overall pattern of rate reduction may
differ somewhat among drugs in that some
drugs may modify aspects of the pattern of
drug-maintained responding that are less af-
fected by other drugs. However, as dose and
total drug intake continue to increase, the net
effect is further suppression of responding, re-
flected in a general lengthening of pause time
and run time.
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